Full Year 2019 Allergy Therapeutics PLC Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Allergy Therapeutics Company update conference call. (Operator Instructions) As a reminder, today's conference call is being recorded. (Operator Instructions)
(technical difficulty)
today with me Nick Wykeman, and we'll share the year-end results.
So let's -- for those of you that are on the phone, we are starting straightforward into Page #5 of the presentation, the 3 pillars of growth. We've shown this slide sometimes. Sorry, yes, I said that it was well. So we've -- these are the 3 key areas of development of the company: developing the company in Europe, developing the pipeline and preparing for the U.S. entry.
If we go now to Page #7, we see how we have done in our first focus area, which is developing the company in Europe. It's been a good year. We have faced a more complex scenario this year, not only because of the Brexit preparations, we are the only competitor that have had to face that. But also, we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
